|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
3,001 |
$80,090.81 |
2.62% |
| ResMed Inc. |
RMD |
761152107 |
328 |
$70,900.48 |
2.32% |
| Hoya Corporation |
7741.JP |
J22848105 |
594 |
$70,651.60 |
2.31% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
3,912 |
$67,862.45 |
2.22% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
1,826 |
$66,488.94 |
2.17% |
| Boston Scientific Corporation |
BSX |
101137107 |
896 |
$65,793.28 |
2.15% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
13,578 |
$64,668.58 |
2.11% |
| Insulet Corporation |
PODD |
45784P101 |
348 |
$64,129.44 |
2.09% |
| Olympus Corporation |
7733.JP |
J61240107 |
4,340 |
$64,094.61 |
2.09% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,734 |
$63,993.79 |
2.09% |
| Cochlear Limited |
COH.AU |
Q25953102 |
295 |
$63,819.58 |
2.08% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
5,101 |
$63,670.77 |
2.08% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
217 |
$63,784.20 |
2.08% |
| Steris Plc |
STE |
G8473T100 |
299 |
$63,648.13 |
2.08% |
| Danaher Corporation |
DHR |
235851102 |
254 |
$63,185.04 |
2.06% |
| Medtronic Plc |
MDT |
G5960L103 |
761 |
$62,325.90 |
2.04% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,342 |
$61,998.37 |
2.02% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
159 |
$61,795.35 |
2.02% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
108 |
$61,869.96 |
2.02% |
| Becton, Dickinson and Company |
BDX |
075887109 |
259 |
$61,421.85 |
2.01% |
| Shockwave Medical, Inc. |
SWAV |
82489T104 |
186 |
$61,471.14 |
2.01% |
| Waters Corporation |
WAT |
941848103 |
189 |
$61,625.34 |
2.01% |
| Agilent Technologies, Inc. |
A |
00846U101 |
433 |
$61,169.91 |
2.00% |
| Terumo Corporation |
4543.JP |
J83173104 |
3,560 |
$61,380.04 |
2.00% |
| The Cooper Companies, Inc. |
COO |
216648501 |
652 |
$60,909.84 |
1.99% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
1,180 |
$60,604.80 |
1.98% |
| Revvity, Inc. |
RVTY |
714046109 |
589 |
$60,767.13 |
1.98% |
| Alcon Inc. |
ALC.SW |
H01301128 |
749 |
$60,434.33 |
1.97% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
561 |
$60,135.38 |
1.96% |
| Hologic, Inc. |
HOLX |
436440101 |
789 |
$60,042.90 |
1.96% |
| Masimo Corporation |
MASI |
574795100 |
442 |
$60,112.00 |
1.96% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
48 |
$59,891.52 |
1.96% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,074 |
$60,075.51 |
1.96% |
| Stryker Corporation |
SYK |
863667101 |
178 |
$59,120.92 |
1.93% |
| Abbott Laboratories |
ABT |
002824100 |
553 |
$58,712.01 |
1.92% |
| BioMerieux |
BIM.FP |
F1149Y232 |
549 |
$58,937.65 |
1.92% |
| Penumbra, Inc. |
PEN |
70975L107 |
280 |
$58,800.00 |
1.92% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
160 |
$58,936.00 |
1.92% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
481 |
$58,407.83 |
1.91% |
| DexCom, Inc. |
DXCM |
252131107 |
448 |
$58,284.80 |
1.90% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
676 |
$58,027.84 |
1.90% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
707 |
$57,571.01 |
1.88% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
472 |
$57,331.80 |
1.87% |
| Teleflex Incorporated |
TFX |
879369106 |
284 |
$57,231.68 |
1.87% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
203 |
$56,821.73 |
1.86% |
| Baxter International Inc. |
BAX |
071813109 |
1,512 |
$54,613.44 |
1.78% |
| Align Technology, Inc. |
ALGN |
016255101 |
189 |
$54,152.28 |
1.77% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
855 |
$52,505.55 |
1.71% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
229 |
$51,286.86 |
1.67% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
391 |
$50,988.76 |
1.67% |
| US Dollar |
$USD |
|
5,549 |
$5,548.99 |
0.18% |
| Euro |
$EUR |
|
0 |
$0.03 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.06 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|